ArKal Medical Raises $17.5M

Fremont-based ArKal Medical said today that the firm has raised $17.5M in a Series B financing round. The firm, which is developing a continuous glucose monitoring system for managing diabetes, said the round was led by Thomas Mcnerney & Partners. Delphi Ventures and MedVenture Associates also participated in the round. ArKal's products are intended to replace current glucose monitoring systems. More information »